Cytochrome P4501B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer

被引:23
|
作者
Wen, Xia [1 ]
Walle, Thomas [1 ]
机构
[1] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA
关键词
esophageal carcinogenesis; benzo[a]pyrene; CYP1B1; methoxylated flavones;
D O I
10.1016/j.canlet.2006.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Esophageal cancer is common worldwide, with poor prognosis. Smoking, including exposure to polyaromatic hydrocarbons like benzo[a]pyrene (BaP), is a major risk factor. In human esophageal HET-1A cells, we found that time-dependent BaP-DNA binding was associated with upregulation of CYP1B1, but not CYP1A1, mRNA and protein. The dietary flavonoid 5,7-dimethoxyflavone significantly inhibited BaP-DNA binding and down-regulated BaP-induced CYP1B1 mRNA and protein. 3',4'-Dimethoxyflavone was an even more potent inhibitor of CYP1B1 expression, while resveratrol had no effect. Thus, dietary methoxylated flavones inhibited BaP-induced CYP1B1 transcription in a cell-specific manner and hold promise as chemopreventive agents in esophageal carcinogenesis. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [1] Novel bioavailable inhibitors of benzo[a]pyrene-induced cytochrome P4501B1 mRNA in human oral epithelial cells
    Walle, T
    Walle, UK
    Carter, LG
    Wen, X
    FASEB JOURNAL, 2006, 20 (04): : A262 - A262
  • [2] Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P4501B1 (vol 19, pg 1847, 1998)
    Kim, JH
    Stansbury, KH
    Walker, NJ
    Trush, MA
    Strickland, PT
    Sutter, TR
    CARCINOGENESIS, 1999, 20 (03) : 515 - 515
  • [3] Expression of human cytochrome P4501B1 in bacteria
    Guengerich, FP
    Shimada, T
    Gillam, EMJ
    Sutter, TR
    Wunsch, RM
    FASEB JOURNAL, 1998, 12 (08): : A1425 - A1425
  • [4] Cytochrome P4501B1: a target for inhibition in anticarcinogenesis strategies
    Guengerich, FP
    Chun, YJ
    Kim, D
    Gillam, EMJ
    Shimada, T
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 523 : 173 - 182
  • [5] Genotyping human cytochrome: P4501B1 variants
    Sutter, CH
    Qian, Z
    Hong, YP
    Mammen, JS
    Strickland, PT
    Sutter, TR
    CYTOCHROME P450, PT C, 2002, 357 : 53 - 58
  • [6] MicroRNA regulates the expression of human cytochrome P4501B1
    Tsuchiya, Yuki
    Nakajima, Miki
    Takagi, Shingo
    Taniya, Takao
    Yokoi, Tsuyoshi
    CANCER RESEARCH, 2006, 66 (18) : 9090 - 9098
  • [7] Specificity of 17β-oestradiol and benzo[a] pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432
    Shimada, T
    Watanabe, J
    Inoue, K
    Guengerich, FP
    Gillam, EMJ
    XENOBIOTICA, 2001, 31 (03) : 163 - 176
  • [8] Identification of dietary polyphenols as inhibitors of benzo[a]pyrene-induced cytochrome P4501B1 mRNA in human oral epithelial cells.
    Walle, T
    Walle, UK
    Carter, LG
    Wen, X
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2747S - 2747S
  • [9] Catalytic properties of polymorphic human cytochrome P4501B1 variants
    Shimada, T
    Watanabe, J
    Kawajiri, K
    Sutter, TR
    Guengerich, FP
    Gillam, EMJ
    Inoue, K
    CARCINOGENESIS, 1999, 20 (08) : 1607 - 1613
  • [10] Polymorphisms of cytochrome P4501B1 are risk factors for prostate cancer
    Tanaka, Y
    Sasaki, M
    Shiina, H
    Igawa, M
    Kaneuchi, M
    Kane, CJ
    Carroll, PR
    Dahiya, R
    JOURNAL OF UROLOGY, 2004, 171 (04): : 111 - 111